4.6 Review

C9orf72loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD?

期刊

ACTA NEUROPATHOLOGICA
卷 140, 期 5, 页码 625-643

出版社

SPRINGER
DOI: 10.1007/s00401-020-02214-x

关键词

C9orf72; Repeat expansion; Amyotrophic lateral sclerosis; Frontotemporal dementia; Loss-of-function; Neurodegeneration; Postmortem; In vitro; In vivo

资金

  1. VIB
  2. KU Leuven (C1)
  3. KU Leuven (Opening the Future Fund)
  4. Fund for Scientific Research Flanders (FWO-Vlaanderen) [G0C1620N]
  5. Thierry Latran Foundation
  6. Association Belge contre les Maladies neuro-Musculaires-aide a la recherche ASBL (ABMM)
  7. Muscular Dystrophy Association (MDA)
  8. ALS Liga Belgie (A Cure for ALS)
  9. Target ALS
  10. ALS Association (ALSA)

向作者/读者索取更多资源

A repeat expansion inC9orf72is responsible for the characteristic neurodegeneration in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) in a still unresolved manner. Proposed mechanisms involve gain-of-functions, comprising RNA and protein toxicity, and loss-of-function of theC9orf72gene. Their exact contribution is still inconclusive and reports regarding loss-of-function are rather inconsistent. Here, we review the function of the C9orf72 protein and its relevance in disease. We explore the potential link between reduced C9orf72 levels and disease phenotypes in postmortem, in vitro, and in vivo models. Moreover, the significance of loss-of-function in other non-coding repeat expansion diseases is used to clarify its contribution inC9orf72ALS/FTD. In conclusion, with evidence pointing to a multiple-hit model, loss-of-function on itself seems to be insufficient to cause neurodegeneration inC9orf72ALS/FTD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据